Dear Reader,

The excitement is building…

We’ll soon be launching a new letter focused on longevity and biotech investments.

Currently, we have over 6,700 people signed up on the waitlist.

Thank you for all your support and interest!

This is a passion project for John Mauldin and he’s happy to have so many friends along for the journey.

We’re also excited to have our old friend, Patrick Cox, as a part of this project.

For years, Patrick has been focused professionally on identifying biotechnologies that have important impacts on healthspan.

Based on the evidence, he believes we’re on the verge of reversing age and dramatically extending healthy lifespans.

As is often the case in an emerging field, there is a lot of misinformation and hyperbole around the latest developments.

To help our readers, Patrick has put together a free special report on “Longevity Myths and Solutions.”

Inside, he discusses some of the leading myths around longevity as well as simple ways you can improve your healthspan starting today.

To get Patrick’s free special report, additional bonuses, and all the updates on this coming letter, sign up here.

We hope you’ll join us!

Best Regards,

Mauldin Economics

In summary: Mauldin Economics is launching a new letter focused on the latest longevity and biotech investing recommendations. Our old friend Patrick Cox will be a part of this project. To help our readers, Patrick has put together a free special report on “Longevity Myths and Solutions.” You can sign up here to download it for free.